CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.

K. Tsoyi,Xiaoliang Liang,Giulia De Rossi,Stefan W. Ryter,Kevin Xiong,Sarah G. Chu,Xiaoli Liu,Bonna Ith,Lindsay J Celada,Freddy Romero,Matthew J. Robertson,Anthony J. Esposito,Sergio Poli,Souheil El-Chemaly,Mark A. Perrella,Yuanyuan Shi,James R. Whiteford,Ivan O. Rosas

CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.

2021

K. Tsoyi
Xiaoliang Liang
Giulia De Rossi
Stefan W. Ryter
Kevin Xiong
Sarah G. Chu
Xiaoli Liu
Bonna Ith
Lindsay J Celada
Freddy Romero
Matthew J. Robertson
Anthony J. Esposito
Sergio Poli
Souheil El-Chemaly
Mark A. Perrella
Yuanyuan Shi
James R. Whiteford
Ivan O. Rosas

Rationale: The receptor-like protein tyrosine phosphatase eta (CD148/PTPRJ) exerts anti-fibrotic effects in experimental pulmonary fibrosis via interactions with its ligand syndecan-2; however, the...

Keywords:

Cancer research
Syndecan-2
nuclear factor kappa b
Idiopathic pulmonary fibrosis
protein tyrosine phosphatase eta
Medicine
Ligand (biochemistry)
Pulmonary fibrosis
Fibroblast

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations